David Shulman, MD

Dr. Shulman is a Pediatric Oncologist, a clinical/translational researcher at the Dana-Farber/Boston Children’s Cancer and Blood Disorders Center (DFCI/BCH), and an Assistant Professor of Pediatrics at Harvard Medical School (HMS). His research focuses on improving outcomes for adolescents and young adults (AYA) with sarcomas through investigation of novel biomarkers and therapies.

His clinical focus is on the care of AYAs (40 years and younger) with sarcomas. He is the director of the DFCI AYA Sarcoma Program, which is dedicated to improving outcomes for AYAs with sarcomas through comprehensive clinical care and collaborative research.